1 |
Wong, H. T., Cheng, S. C., Chan, E. W., Sheng, Z. T., Yan, W. Y., Zheng, Z. X. and Xie, Y. (2000) Plasmids encoding foot-and-mouth disease virus VPl epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278, 27-35
DOI
ScienceOn
|
2 |
Grubman, M. J., Morgan, D. O., Kendall J. and Baxt, B. (1985) Capsid intermediates assembled in a foot-and-mouth disease virus genome RNA-programmed cell-free translation system and in infected cells. J. Virol. 56, 120-6
|
3 |
Jackson, T., Ellard, F. M., Ghazaleh, R. A., Brookes, S. M., Blakemore, W. E., Corteyn, A. H., Stuart, D. I., Newman, J. W. and King, A. M. (1996) Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Viral. 70, 5282-5287
|
4 |
McCullough, K. C., De Simone, F., Brocchi, E., Capucci, L., Crowther, J. R. and Kihm, U. (1992) Protective immune response against foot-and-mouth disease. J. Viral. 66, 1835-1840
|
5 |
Collen, T. and Doel, T. R. (1990) Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. J. Gen. Viral. 71, Pt 2, 309-315
DOI
ScienceOn
|
6 |
Sobrino, F., Saiz, M., Jimenez-Clavero, M. A., Nunez, J. I., Rosas, M. F., Baranowski, E. and Ley, V. (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet. Res. 32, 1-30
DOI
ScienceOn
|
7 |
Alexandersen, S., Zhang, Z., Donaldson, A. I. and Garland, A. J. (2003) The pathogenesis and diagnosis of foot-and-mouth disease. J. Camp. Pathol. 129, 1-36
DOI
ScienceOn
|
8 |
Chenard, G., Miedema, K., Moonen, P., Schrijver, R. S. and Dekker, A. (2003) A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology. J. Viral. Methods. 107, 89-98
DOI
ScienceOn
|
9 |
Chamberlain, J. S., Gibbs, R. A., Ranier, J. E., Nguyen, P. N. and Caskey, C. T. (1988) Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic. Acids. Res. 16, 11141-11156
DOI
ScienceOn
|
10 |
Doel, T. R. (1996) Natural and vaccine-induced immunity to foot and mouth disease: the prospects for improved vaccines. Rev. Sci. Tech. 15, 883-911
|
11 |
Ishimaru, D., Sa-Carvalho, D. and Silva, J. L. (2004) Pressure-inactivated FMDV: a potential vaccine. Vaccine 22, 2334-9
DOI
ScienceOn
|
12 |
Sanz-Parra, A., Vazquez, B., Sobrino, F., Cox, S. J., Ley, V. and Salt, J. S. (1999) Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J. Gen. Virol. 80, Pt 3, 671-679
|
13 |
Aggarwal, N. and Barnett, P. V. (2002) Antigenic sites of foot-and-mouth disease virus (FMDV): an analysis of the specificities of anti-FMDV antibodies after vaccination of naturally susceptible host species. J. Gen. Virol. 83, 775-782
|
14 |
Wang, C. Y., Chang, T. Y., Walfield, A. M., Ye, J., Shen, M., Chen, S. P., Li, M. C., Lin, Y. L., Jong, M. H., Yang, P. C., Chyr, N., Kramer, E. and Brown, F. (2002) Effective synthetic peptide vaccine for foot-and-mouth disease in swine. Vaccine 20, 2603-2610
DOI
ScienceOn
|
15 |
Chinsangaram, J., Beard, C., Mason, P. W., Zellner, M. K., Ward, G. and Grubman, M. J. (1998) Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72, 4454-4457
|
16 |
Cedillo-Barron, L., Foster-Cuevas, M., Belsham, G. J., Lefevre, F. and Parkhouse, R. M. (2001) Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase. J. Gen. Virol. 82, 1713-24
|
17 |
Murdin, A. D. (1986) Synthetic peptide vaccines against foot and mouth disease. Vaccine 4, 210-211
DOI
PUBMED
ScienceOn
|
18 |
Wiesmuller, K. H., Jung, G. and Hess, G. (1989) Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7, 29-33
DOI
ScienceOn
|
19 |
Fischer, D., Rood, D., Barrette, R. W., Zuwallack, A., Kramer, E., Brown, F. and Silbart, L. K. (2003) Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge. J. Virol. 77, 7486-7491
DOI
ScienceOn
|
20 |
Taboga, O., Tami, C., Carrillo, E., Nunez, J. I., Rodriguez, A., Saiz, J. C., Blanco, E., Valero, M. L., Roig, X., Camarero, J. A., Andreu, D., Mateu, M. G., Giralt, E., Domingo, E., Sobrino, F. and Palma, E. L. (1997) A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J. Virol. 71, 2606-2014
|
21 |
Nair, S. P. and Sen, A. K. (1992) A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants. Acta. Virol. 36, 473-478
|
22 |
Garcia-Briones, M. M., Blanco, E., Chiva, C., Andreu, D., Ley, V. and Sobrino, F. (2004) Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology 322, 264-275
DOI
ScienceOn
|
23 |
Shieh, J. J., Liang, C. M., Chen, C. Y., Lee, E, Jong, M. H., Lai, S. S. and Liang, S. M. (2001) Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Vaccine 19, 4002-4010
DOI
ScienceOn
|
24 |
Saiz, M., Nunez, J. I., Jimenez-Clavero, M. A., Baranowski, E. and Sobrino, F. (2002) Foot-and-mouth disease virus: biology and prospects for disease control. Microbes. Infect. 4, 1183-92
DOI
ScienceOn
|
25 |
Yilma, T. (1980) Morphogenesis of vesiculation in foot-and-mouth disease. Am. J. Vet. Res. 41, 1537-1542
|
26 |
Wang, C. Y., Chang, T. Y., Walfield, A. M., Ye, J., Shen, M., Zhang, M. L., Lubroth, J., Chen, S. P., Li, M. C., Lin, Y. L., Jong, M. H., Yang, P. C., Chyr, N., Kramer, E. and Brown, F. (2001) Synthetic peptide-based vaccine and diagnostic system for effective control of FMD. Biologicals 29, 221-228
DOI
ScienceOn
|
27 |
Clavijo, A., Wright, P. and Kitching, P. (2004) Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease. Vet. J. 167, 9-22
DOI
ScienceOn
|
28 |
Ward, G, Rieder, E. and Mason, P. W. (1997) Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine. J. Virol. 71, 7442-7447
|
29 |
Leforban, Y. (1999) Prevention measures against foot-and-mouth disease in Europe in recent years. Vaccine 17, 1755-1759
DOI
ScienceOn
|
30 |
McInerney, G. M., King, A. M., Ross-Smith, N. and Belsham, G. J. (2000) Replication-competent foot-and-mouth disease virus RNAs lacking capsid coding sequences. J. Gen. Virol. 81, 1699-1702
|
31 |
Sanz-Parra, A., Sobrino, F. and Ley, V. (1998) Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J. Gen. Viral. 79, Pt 3, 433-436
|
32 |
Mackay, D. K., Bulut, A. N., Rendle, T., Davidson, F. and Ferris, N. P. (2001) A solid-phase competition ELISA for measuring antibody to foot-and-mouth disease virus. J. Viral. Methods. 97, 33-48
DOI
PUBMED
ScienceOn
|
33 |
Stratford, R, Douce, G., Bowe, F. and Dougan, G. (2001) A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC). Vaccine 20, 516-525
DOI
ScienceOn
|
34 |
Kitching, R. P. (1998) A recent history of foot-and-mouth disease. J. Compo. Pathol. 118, 89-108
DOI
PUBMED
ScienceOn
|
35 |
Meloen, R. H., Casal, J. I., Dalsgaard, K. and Langeveld, J. P. (1995) Synthetic peptide vaccines: success at last. Vaccine 13, 885-886
DOI
ScienceOn
|
36 |
Grubman, M. J. and Baxt, B. (2004) Foot-and-mouth disease. Clin. Microbiol. Rev. 17, 465-93
DOI
ScienceOn
|
37 |
Zheng, L. Y., Moll, L., Lin, S., Lu, R M. and Luo, E. J. (2005) Enhancing DNA vaccine potency against hantavirus by co-administration of interleukin-12 expression vector as a genetic adjuvant. Chin. Med. J. (Engl). 118, 313-319
|
38 |
M. J. Francis, G. Z. Hastings, F. Brown, J. Mcdermed, Y. A Lu. and J. P. Tam, (1991) Immunological evaluation of the multiple antigen peptide (Map) system using the major immunogenic site of foot-and-mouth-disease virus. Immunology 73, 249-254
|
39 |
Brown, F. (1992) New approaches to vaccination against foot-and-mouth disease. Vaccine 10, 1022-1026
DOI
PUBMED
ScienceOn
|
40 |
Brown, C. C., Piccone, M. E., Mason, P. W., McKenna, T. S. and Grubman, M. J. (1996) Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J. Viral. 70, 5638-5641
|
41 |
Moraes, M. P., Mayr, G. A, Mason, P. W. and Grubman, M. J. (2002) Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 20, 1631-1639
DOI
ScienceOn
|
42 |
Donnelly, M. L., Hughes, L. E., Luke, G, Mendoza, H., ten Dam, E., Gani, D. and Ryan, M. D. (2001) The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J. Gen. Viral. 82, 1027-1041
|
43 |
Donnelly, M. L., Gani, D., Flint, M., Monaghan, S. and Ryan, M. D. (1997) The cleavage activities of aphthovirus and cardiovirus 2A proteins. J. Gen. Viral. 78, 13-21
|
44 |
Reid, S. M., Forsyth, M. A., Hutchings, G. H. and Ferris, N. P. (1998) Comparison of reverse transcription polymerase chain reaction, enzyme linked immunosorbent assay and virus isolation for the routine diagnosis of foot-and-mouth disease. J. Viral. Methods. 70, 213-217
DOI
ScienceOn
|
45 |
Cedillo-Barron, L., Foster-Cuevas, M., Cook, A., Gutierrez-Castaneda, B., Kollnberger, S., Lefevre, F. and Parkhouse, R. M. (2003) Immunogenicity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21, 4261-4269
DOI
ScienceOn
|
46 |
Chan, E. W., Wong, H. T., Cheng, S. C., Yan, W. Y., Zheng, Z. X, Sheng, Z. T., Zhu, L. Q. and Xie, Y. (2000) An immunoglobulin G based chimeric protein induced foot-and-mouth disease specific immune response in swine. Vaccine 19, 538-546
DOI
ScienceOn
|
47 |
Li, Y., Aggarwal, N., Takamatsu, H. H., Sterling, C. M., Voyce, C. and Barnett, P. V. (2005) Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine
|
48 |
Doedens, J. R. and Kirkegaard, K. (1995) Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. Embo. J. 14, 894-907
|
49 |
Bittle, J. L., Houghten, R. A., Alexander, H., Shinnick, T. M., Sutcliffe, J. G., Lerner, R A, Rowlands, D. J. and Brown, E (1982) Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298, 30-33
DOI
ScienceOn
|
50 |
Logan, D., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Jackson, T., King, A., Lea, S., Lewis, R., Newman, J., Party, N. and et al. (1993) Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362, 566-568
DOI
ScienceOn
|
51 |
Strohmaier, K., Franze, R. and Adam, K. H. (1982) Location and characterization of the antigenic portion of the FMDV immunizing protein. J. Gen. Virol. 59, 295-306
DOI
ScienceOn
|
52 |
Glass, E. J., Oliver, R. A, Collen, T., Doel, T. R., Dimarchi, R. and Spooner, R. L. (1991) MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology 74, 594-599
|
53 |
Curry, S., Fry, E., Blakemore, W., Abu-Ghazaleh, R., Jackson, T., King, A., Lea, S., Newman, J. and Stuart, D. (1997) Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J. Virol. 71, 9743-9752
|
54 |
Chattergoon, M., Boyer, J. and Weiner, D. B. (1997) Genetic immunization: a new era in vaccines and immune therapeutics. Faseb. J. 11, 753-763
|
55 |
Rodriguez, L. L., Barrera, J., Kramer, E., Lubroth, J., Brown, F. and Golde, W. T. (2003) A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 21, 3751-3756
DOI
ScienceOn
|
56 |
Fry, E. E., Stuart, D. I. and Rowlands, D. J. (2005) The structure of foot-and-mouth disease virus. Curr. Top. Microbiol. Immunol. 288, 71-101
DOI
|
57 |
Beard, C., Ward, G, Rieder, E., Chinsangaram, J., Grubman, M. J. and Mason, P. W. (1999) Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73, 243-249
DOI
ScienceOn
|
58 |
Beignon, A. S., Brown, F., Eftekhari, P., Kramer, E., Briand, J. P., Muller, S. and Partidos, C. D. (2005) A peptide vaccine administered transcutaneously together with cholera toxin elicits potent neutralising anti-FMDV antibody responses. Vet. Immunol. Immunopathol. 104, 273-280
DOI
ScienceOn
|
59 |
Verdaguer, N., Mateu, M. G, Andreu, D., Giralt, E., Domingo, E. and Fita, I. (1995) Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. Embo. J. 14, 1690-1696
|
60 |
Carrillo, C., Wigdorovitz, A., Oliveros, J. C., Zamorano, P. I., Sadir, A. M., Gomez, N., Salinas, J., Escribano, J. M. and Borca, M. V. (1998) Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. J. Virol. 72, 1688-1690
|
61 |
Wigdorovitz, A., Carrillo, C., Dus Santos, M. J., Trono, K., Peralta, A., Gomez, M. C., Rios, R. D., Franzone, P. M., Sadir, A. M., Escribano, J. M. and Borca, M. V. (1999) Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255, 347-353
DOI
ScienceOn
|
62 |
Song, H., Wang, Z., Zheng, D., Fang, W., Li, Y., Liu, Y., Niu, Z. and Qiu, B. (2005) A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine. Biotechnol. Lett. 27, 1669-1674
DOI
ScienceOn
|
63 |
Wang, C. Y. and Walfield, A. M. (2005) Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications. Vaccine 23, 2049-2056
DOI
ScienceOn
|
64 |
Nargi, F., Kramer, E., Mezencio, J., Zamparo, J., Whetstone, C., Van Regenmortel, M. H., Briand, J. P., Muller, S. and Brown, F. (1999) Protection of swine from foot-and-mouth disease with one dose of an all-D retro peptide. Vaccine 17, 2888-2893
DOI
ScienceOn
|